Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
05/2010
05/20/2010WO2010055267A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/20/2010WO2010055164A2 Novel inhibitors of flavivirus replication
05/20/2010WO2010054926A1 4-halo-3 -amino- l, 2 -benzisothiazole compounds as pesticides
05/20/2010WO2010054762A1 Aminoalkyl-substituted compounds as hif inhibitors
05/20/2010WO2010054528A1 Quinazoline compounds
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010WO2010013078A8 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
05/20/2010WO2009049798A8 Iminoheterocycles for insecticides
05/20/2010US20100125080 Compounds for inflammation and immune-related uses
05/20/2010US20100125075 Antibacterial Agents
05/20/2010US20100125073 Benzofuran and benzothiophene derivatives useful in the treatment of cancers of the central nervous system
05/20/2010US20100125065 Carboline derivatives useful in the inhibition of angiogenesis
05/20/2010US20100124543 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
05/20/2010CA2743558A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/20/2010CA2743483A1 Tetrasubstituted pyridazine hedgehog pathway antagonists
05/20/2010CA2742993A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
05/20/2010CA2742833A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010CA2742297A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/19/2010EP2186811A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/19/2010EP2186803A2 Substituted thioacetamides
05/19/2010EP2186516A1 Novel benzazepine derivative
05/19/2010EP2186410A1 Isoxazoline derivative and herbicide comprising the same as active ingredient
05/19/2010EP2185552A1 Dipeptoid prodrugs and the use thereof
05/19/2010EP2185551A2 Prodrugs of 2-amino-6-( { [2-(4-chlorphenyl)-1,3-thiazol-4-yl] methyl}thio)-4-[4-(2-hy-droxyethoxy) phenyl] pyridin-3, 5-dicarbonitrile
05/19/2010EP2185548A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
05/19/2010EP2185544A2 N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
05/19/2010EP2185539A1 Viral polymerase inhibitors
05/19/2010EP2185524A1 Novel peptide inhibitors of hepatitis c virus replication
05/19/2010EP2185514A1 Vinyl-aryl derivatives for inflammation and immune-related uses
05/19/2010EP2185512A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
05/19/2010EP2185507A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
05/19/2010EP2184994A1 Heterocycle-aryl compounds for inflammation and immune-related uses
05/19/2010EP1599467B1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
05/19/2010EP1490359B1 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/19/2010CN101711247A 2-cyclopropyl-thiazole derivatives
05/19/2010CN101711245A 5-membered heterocyclic amides and related compounds
05/19/2010CN101711238A 1, 3 - dihydroxy substituted phenylamide glucokinase activators
05/18/2010US7718808 adenosine A2A receptor antagonists; N-[4-(2-Furyl)-5-(4-pyridyl)thiazol-2-yl]pyridine-4-carboxamide; treatment of Parkinson's disease, Alzheimer's disease, progressive supranuclear palsy, AIDS encephalopathy, nerve system disorders
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718691 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
05/18/2010US7718681 CDC25B phosphatase inhibitors; side effect reduction; Vilsmeier-Haack reaction; alkenylation reaction of thiazolo-2,4-dione; methenylation reaction using acetophenone derivative
05/18/2010US7718673 Heterocyclic amides such as beta-(((1-(4-((4,5-dihydro-1H-imidazol-2-yl)amino)-1-oxobutyl)-4 -piperidinyl)carbonyl)amino) -,(beta 3S)-3-quinolinepropanoic acid, used as antagonists for cellular adhesion molecules
05/18/2010US7718659 Coagulation factor Xa inhibitors; such as [4-(2-[1,4']-Bipiperidinyl-1'-yl-2-oxo-ethyl)-thiazol-2-yl]-4-chloro-benzamide
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/14/2010WO2010054107A2 Kinase knockdown via electrophilically enhanced inhibitors
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054024A2 Novel compounds as cannabinoid receptor ligands
05/14/2010WO2010053732A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010WO2010053218A1 Fluorinated benzothiazole derivatives, preparation method thereof and imaging agent for diagnosing altzheimer's disease using the same
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010053120A1 Carbamate compound or salt thereof
05/14/2010WO2010052199A1 Heterocyclic gamma secretase modulators
05/14/2010WO2010051977A1 Substituted disulfonamides as bri-modulators
05/14/2010WO2010015652A3 Thiazole compounds as medicaments for the treatment of (inter alia) cardiovascular diseases
05/14/2010WO2010014240A3 Novel bioactive small molecules derived from sea sponges
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010WO2009156484A3 Organic compounds
05/14/2010WO2009134616A8 Novel inhibitors of hepatitis c virus replication
05/14/2010CA2743196A1 Heterocyclic gamma secretase modulators
05/14/2010CA2742741A1 Substituted disulfonamides
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2742515A1 Modulators of cxcr7
05/14/2010CA2741990A1 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
05/14/2010CA2741500A1 Carbamate compound or salt thereof
05/14/2010CA2741299A1 Isoindoline compounds for use in the treatment of cancer
05/14/2010CA2741047A1 Novel compounds as cannabinoid receptor ligands
05/13/2010US20100121063 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
05/13/2010US20100121059 5-PHENOXYALKOXYPSORALENS AND METHODS FOR SELECTIVE INHIBITION OF THE VOLTAGE GATED Kv1.3 POTASSIUM CHANNEL
05/13/2010US20100121057 Process for the Preparation of Piperazine Benzothiazoles
05/13/2010US20100121052 Novel compounds for treating proliferative diseases
05/13/2010US20100121048 Cyclic Amine Compound and Use Thereof for the Prophylaxis or Treatment of Hypertension
05/13/2010US20100120865 thiazol-2-yl-urea derivatives such as 3-{3-[4-Methyl-5-(4-pyrazol-1-yl-phenyl)-thiazol-2-yl]-ureido}-N-pyridin-3-yl-propionamide, used in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase, particularly inflammatory, allergic or autoimmune conditions
05/13/2010US20100120860 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
05/13/2010US20100120804 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/13/2010US20100120794 Cycloalkylamino Acid Derivatives
05/13/2010US20100120784 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
05/13/2010US20100120759 Azadecalin glucocorticoid receptor modulators
05/13/2010US20100120757 Pyrazolone derivatives as pde4 inhibitors
05/13/2010US20100120714 Substituted benzene fungicides
05/13/2010US20100119475 Novel inhibitors of glutaminyl cyclase
05/12/2010EP2184285A1 Heterocyclic compound and use thereof
05/12/2010EP2183248A2 Benzimidazole poly (adp ribose) polymerase inhibitors
05/12/2010EP2183246A2 2-aza-bicyclo-[3.3.0]-octane derivatives
05/12/2010EP2183237A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
05/12/2010EP2183232A2 Pi3 kinase modulators and methods of use
05/12/2010EP2183229A1 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
05/12/2010EP2183228A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1
05/12/2010EP2183225A1 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183221A1 New compounds as hsp90 inhibitors
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP2182808A1 Pyridine compounds for inflammation and immune-related uses
05/12/2010EP2121674B1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
05/12/2010EP1564210B9 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
05/12/2010EP1373262B1 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors
05/12/2010CN1989139B Benzothiazole derivatives
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 628